200 related articles for article (PubMed ID: 24330843)
1. Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma.
Xing X; Lian S; Hu Y; Li Z; Zhang L; Wen X; Du H; Jia Y; Zheng Z; Meng L; Shou C; Ji J
J Transl Med; 2013 Dec; 11():309. PubMed ID: 24330843
[TBL] [Abstract][Full Text] [Related]
2. Phosphatase of regenerating liver-3 localizes to cyto-membrane and is required for B16F1 melanoma cell metastasis in vitro and in vivo.
Song R; Qian F; Li YP; Sheng X; Cao SX; Xu Q
PLoS One; 2009; 4(2):e4450. PubMed ID: 19214221
[TBL] [Abstract][Full Text] [Related]
3. Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis.
Li ZR; Wang Z; Zhu BH; He YL; Peng JS; Cai SR; Ma JP; Zhan WH
Surg Today; 2007; 37(8):646-51. PubMed ID: 17643206
[TBL] [Abstract][Full Text] [Related]
4. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692
[TBL] [Abstract][Full Text] [Related]
5. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study.
Miskad UA; Semba S; Kato H; Matsukawa Y; Kodama Y; Mizuuchi E; Maeda N; Yanagihara K; Yokozaki H
Virchows Arch; 2007 Mar; 450(3):303-10. PubMed ID: 17235563
[TBL] [Abstract][Full Text] [Related]
6. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy.
Bilici A; Ustaalioglu BB; Yavuzer D; Seker M; Mayadagli A; Gumus M
Dig Dis Sci; 2012 Jun; 57(6):1568-75. PubMed ID: 22331511
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer.
Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Waraya M; Kawamata H; Nishimiya H; Nakamura K; Watanabe M
BMC Cancer; 2011 Apr; 11():122. PubMed ID: 21466710
[TBL] [Abstract][Full Text] [Related]
9. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN.
Xiong J; Li Z; Zhang Y; Li D; Zhang G; Luo X; Jie Z; Liu Y; Cao Y; Le Z; Tan S; Zou W; Gong P; Qiu L; Li Y; Wang H; Chen H
Oncol Rep; 2016 Oct; 36(4):1819-28. PubMed ID: 27572739
[TBL] [Abstract][Full Text] [Related]
10. PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer.
Pryczynicz A; Guzińska-Ustymowicz K; Niewiarowska K; Cepowicz D; Kemona A
Tumour Biol; 2014 Jul; 35(7):6587-92. PubMed ID: 24696260
[TBL] [Abstract][Full Text] [Related]
11. Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis.
Hu L; Luo H; Wang W; Li H; He T
PLoS One; 2013; 8(10):e76927. PubMed ID: 24204707
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference.
Wang Z; He YL; Cai SR; Zhan WH; Li ZR; Zhu BH; Chen CQ; Ma JP; Chen ZX; Li W; Zhang LJ
Int J Cancer; 2008 Sep; 123(6):1439-47. PubMed ID: 18561324
[TBL] [Abstract][Full Text] [Related]
13. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.
Zhang C; Tian W; Meng L; Qu L; Shou C
J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949
[TBL] [Abstract][Full Text] [Related]
14. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis.
Miskad UA; Semba S; Kato H; Yokozaki H
Pathobiology; 2004; 71(4):176-84. PubMed ID: 15263806
[TBL] [Abstract][Full Text] [Related]
15. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo.
Matsukawa Y; Semba S; Kato H; Koma Y; Yanagihara K; Yokozaki H
Pathobiology; 2010; 77(3):155-62. PubMed ID: 20516731
[TBL] [Abstract][Full Text] [Related]
16. Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer.
Dai N; Lu AP; Shou CC; Li JY
World J Gastroenterol; 2009 Mar; 15(12):1499-505. PubMed ID: 19322925
[TBL] [Abstract][Full Text] [Related]
17. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
[TBL] [Abstract][Full Text] [Related]
18. Methylation-associated silencing of miR-495 inhibit the migration and invasion of human gastric cancer cells by directly targeting PRL-3.
Li Z; Zhang G; Li D; Jie Z; Chen H; Xiong J; Liu Y; Cao Y; Jiang M; Le Z; Tan S
Biochem Biophys Res Commun; 2015 Jan; 456(1):344-50. PubMed ID: 25475733
[TBL] [Abstract][Full Text] [Related]
19. miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3.
Li Z; Cao Y; Jie Z; Liu Y; Li Y; Li J; Zhu G; Liu Z; Tu Y; Peng G; Lee DW; Park SS
Cancer Lett; 2012 Oct; 323(1):41-47. PubMed ID: 22469786
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
Zhou J; Wang S; Lu J; Li J; Ding Y
Int J Cancer; 2009 Apr; 124(8):1879-86. PubMed ID: 19101992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
